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Introduction
Endoscopic retrograde cholangiopancreatography (ERCP) is a
therapeutic modality used frequently for the management of
most pancreatobiliary disorders. Selective cannulation of the
common bile duct (CBD) is required for most indications, and
is followed by sphincterotomy and further therapeutic inter-
ventions. Successful biliary cannulation is easily achieved in
most patients with a few cannulation attempts in the first few
minutes of the procedure; however, the initial attempts are
not successful in 10%–20% of patients with a native major pa-
pilla, depending on the definition of difficult biliary access.
In such patients with difficult biliary cannulation, advanced
cannulation techniques are used to facilitate biliary access. Dif-
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ABSTRACT
Background and aim While many studies have discussed
the different cannulation techniques used in patients with
difficult biliary access, no previous meta-analyses have
compared transpancreatic sphincterotomy (TPS) to other
advanced techniques. Therefore, we aimed to identify all
studies comparing the efficacy and adverse event rates of
TPS with needle-knife precut papillotomy (NKPP), the most
commonly used technique, and to perform a meta-analysis.
Methods The Embase, PubMed, and Cochrane databases
were searched for trials comparing the outcomes of TPS
with NKPP up till December 2016. A meta-analysis focusing
on outcome (cannulation success, post-endoscopic retro-
grade cholangiopancreatography (ERCP) pancreatitis
(PEP), post-procedural bleeding, and total adverse events)
was performed. The population, intervention, comparison,
outcome (PICO) format was used to compare these cannu-
lation approaches. Five prospective and eight retrospective
studies were included in our meta-analysis.
Results NKPP has a significantly lower success rate (odds
ratio [OR] 0.50, P =0.046; relative risk [RR] 0.92, P=0.03)
and a higher rate of bleeding complications (OR 2.24, P=
0.02; RR 2.18, P=0.02) than TPS.However, no significant
differences were found in PEP (OR 0.79, P=0.24; RR 0.80,
P=0.19), perforation (risk difference [RD] 0.01, P=0.23),
or total complication rates (OR 1.22, P=0.44; RR 1.17, P=
0.47).
Conclusion While TPS has a higher success rate in difficult
biliary access and causes less bleeding than NKPP, there are
no differences in PEP, perforation, or total complication
rates between the two approaches. We conclude that TPS,
in the hands of expert endoscopists, is a safe procedure,
which should be used more widely in patients with difficult
biliary access.
Fig. e2– e5, Table e1,
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ficult cannulation, prolonged cannulation attempts, and ad-
vanced techniques are known to increase the risk of adverse ef-
fects (post-ERCP pancreatitis (PEP), bleeding, perforation, and
cholangitis, among others). The new guideline issued by the
European Society of Gastrointestinal Endoscopy (ESGE) pro-
vides practical advice on achieving successful cannulation while
minimizing the associated risk [1]. The success rate for cannula-
tion may exceed 95% when using these advanced techniques,
while the adverse event rate should remain below 5%, accord-
ing to the recommended new standards of ERCP [2].
Difficult biliary access is defined in the ESGE guideline as
more than five contacts with the papilla while attempting to
cannulate, more than 5 minutes spent attempting to cannulate
after visualization of the papilla, or more than one unintended
pancreatic duct cannulation or opacification [1]. Another new
international consensus defines difficult biliary access similarly,
but extends the time limit for the standard cannulation tech-
nique to 10 minutes [3].
The algorithm recommended in such patients, when the
guidewire cannot be inserted into the pancreatic duct, is nee-
dle-knife precut papillotomy (NKPP) or fistulotomy (NKF) first.
In the case of unintentional pancreatic guidewire (PGW) inser-
tion PGW-assisted cannulation is recommended. The guidewire
is kept in the pancreatic duct, and cannulation of the bile duct is
attempted by injecting contrast material (single-guidewire
technique) or with a second guidewire (double-guidewire
[DGW] cannulation). If biliary access is still not possible, trans-
pancreatic biliary sphincterotomy (TPS) can be performed over
the pancreatic wire with a standard sphincterotome to expose
the biliary orifice.
TPS is a relatively new and underutilized technique, first de-
scribed by Goff et al. [4], with limited outcome data. One ad-
vantage of this method is that the depth of incision is better
controlled by the slow pullback of a traction-type sphinctero-
tome in making the incision toward the 11-o’clock position to
the direction of the CBD than with the free-hand needle-knife
technique. Another advantage is that the sphincterotome
does not need to be changed to a needle-knife. In certain types
of papillary tracts (small, flat, intradiverticular papilla, or the
presence of a small oral protrusion), TPS can be performed
more safely than NKPP or NKF. However, for a protruding or
swollen papilla, NKPP or NKF may be a more appropriate ap-
proach [5].
The alternatives to TPS, needle-knife precut techniques (NKF
or NKPP), are the more frequently used. Early precut papillot-
omy is recommended within 5–10 minutes after the start of
the procedure to decrease the PEP rate and, according to a re-
cent review and meta-analysis [6], NKF seems to be better than
NKPP. While the use of these advanced cannulation techniques
can increase the success rate for CBD cannulation, they also
have the potential to significantly increase the adverse event
rate.
TPS and other precut techniques have not been compared in
any previous meta-analysis. Our aim was, therefore, to identify
all studies that compared the efficacy and adverse event rate of
TPS and NKPP, and to perform a meta-analysis focusing on the
published outcomes for the use of these methods.
Methods
Literature review
A meta-analysis was performed using the population, interven-
tion, comparison, outcome (PICO) format. The selected studies
had looked at: (P) patients with various indications for ERCP
who had difficult biliary access; (I and C) who were managed
with TPS or NKPP; with the outcomes (O) being successful bili-
ary cannulation, PEP, post-procedural bleeding, and total ad-
verse event rate.
The electronic databases of Embase, PubMed, and the Co-
chrane Library were systematically searched for relevant stud-
ies. The systematic review was conducted following the Prefer-
red Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) guidelines (▶Table e1; available online) [7]. All arti-
cles comparing TPS and NKPP were searched irrespective of
the study design, including randomized prospective, non-ran-
domized prospective, and retrospective studies. There were no
restrictions applied regarding the year of publication, lan-
guage, age, sex, or otherwise. Embase, PubMed, and the Co-
chrane Library were searched for synonyms of TPS, which are
interchangeably used in the literature [8]. The search included
the terms “transpancreatic septotomy” OR “transpancreatic
sphincterotomy” OR “transpancreatic septostomy” OR “trans-
pancreatic precut sphincterotomy” OR “pancreatic sphincter-
otomy” OR “transpancreatic papillary septotomy” OR “trans-
pancreatic sphincter precut” OR “transpancreatic duct precut”
OR “pancreatic sphincter precutting” OR “pancreatic precut
sphincterotomy” OR “transpancreatic precut septotomy” OR
“transpancreatic precut septostomy” OR “pancreatic septot-
omy” OR “pancreatic septostomy” OR “pancreatic precut” OR
“transpancreatic precut” OR “transpancreatic”.
The latest date searched was 9 December 2016, which yiel-
ded 453, 306, and 30 articles in the Embase, PubMed, and Co-
chrane databases, respectively. An independent eligibility as-
sessment was performed by each author, and disagreements
were resolved by consensus. Duplicates, repeated publications,
publications available only in abstract form, and review papers
were excluded. The articles selected were published in English
and compared the success and adverse event rates for the dif-
ferent treatment groups retrospectively or prospectively
(▶Fig. 1). Finally, 13 relevant full-text articles, both prospective
and retrospective studies, were included in the quantitative
synthesis of this meta-analysis.
The investigators extracted the data from each publication
independently (number of subjects, method of cannulation,
success rate, and different adverse event rates), and two inves-
tigators (D.P. and Á.V.) then validated these data. Disagree-
ments were discussed and resolved by consensus. This meta-a-
nalysis has not been registered or published previously.
Quality assessment of the studies included
Randomized trials were assessed with the method described by
Jadad et al. [9], while non-randomized studies were evaluated
according to the Methodological Index for Non-Randomized
Studies (MINORS) [10]. Two investigators (D.P. and Á.V.) asses-
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sed the quality of each study included. Disagreements regard-
ing the scoring were resolved by consensus.
Statistical methods
Pooled odds ratios (ORs), relative risks (RRs), and their 95%
confidence intervals (CIs) were calculated to compare the rates
of success, PEP, bleeding, and total complications for the differ-
ent cannulation techniques. The risk difference (RD) was calcu-
lated to compare the perforation rates to avoid overestimation
because OR or RR calculations would exclude those studies
where zero perforations were reported. In the case of a homo-
geneous subset of studies, we used the fixed-effect model de-
scribed by Mantel and Haenszel [11]. The random-effect model
of DerSimonian and Laird [12] was used when we pooled retro-
spective and prospective studies.
Heterogeneity was tested with two methods, namely the Co-
chrane’sQ and the I2 statistics. TheQ test was computed by sum-
ming the squared deviations of each study's estimate from the
overall meta-analysis estimate; P values were obtained by com-
paring the statistical results with a χ2 distribution with k-1 de-
grees of freedom (where k was the number of studies). A P value
of less than 0.05 was considered suggestive of significant het-
erogeneity. The I2 statistic represents the percentage of the total
variability across studies that is due to heterogeneity. I2 values of
25%, 50%, and 75% corresponded to low, moderate, and high
degrees of heterogeneity, respectively, based on Cochrane’s
handbook [13].
Publication bias was examined by visual inspection of funnel
plots, in which the standard error (SE) was plotted against the
net change of outcome (i. e. success rate, complication rates)
for each study.
Meta-analytic calculations were performed with Compre-
hensive MetaAnalysis software Version 3 (Biostat, Inc., Engle-
wood, New Jersey, USA).
Results
Description of the studies selected
Five prospective studies [14–18] and eight retrospective stud-
ies [19–26] were identified during our search. Only two studies
among the prospective studies were randomized, but neither of
these was blinded (▶Table2). All of the studies provided data
on success rates. PEP rate, bleeding rate, and total adverse
event rate were not specified in the TPS group in one study,
where TPS was performed sequentially after failed DGW cannu-
lation [18]. A second study had the same sequential design
[16]. A separate analysis was performed where these two stud-
ies were excluded, and we performed another separate analysis
with the prospective studies.
The Jadad scoring system (where 0 means very poor and 5
means rigorous reporting) [9] was used to assess the two ran-
domized studies. One of these [14] received only one point,
which was because of the poor reporting of the randomization
procedure and the lack of double blinding (which is impossible
to carry out in endoscopic interventional trials). The other ran-
domized trial [17] received three points because the randomi-
zation procedure was appropriately reported (▶Table 2).
The non-randomized studies were assessed using the MIN-
ORS score, in which the maximum score for comparative stud-
ies is 24 [10]. Eight of the eleven studies received a medium
score of 14–16, two trials received higher scores [18, 26],
while only one got an underwhelming 10 points [20] for several
weaknesses (inclusion of non-consecutive patients, more than
5% loss to follow-up, non-equivalent groups, etc.) (▶Table2).
Funnel plot asymmetry tests were used to detect publication
bias. No asymmetry was detected in the assessments of cannu-
lation success rate and PEP rate, while there was asymmetry in
the plots of bleeding and total complication rates (▶Figs. e2–
e5; available online).
789 records identified through database searching:
Embase 453, PubMed 306, Cochrane library 30
349 records screened after duplicates removed
13 studies included in quantitative synthesis 
(meta-analysis)
Synonyms used: 
“transpancreatic septotomy” 
or “transpancreatic sphincterotomy” 
or “transpancreatic septostomy” 
or “transpancreatic precut sphincterotomy” 
or “pancreatic sphincterotomy” 
or “transpancreatic papillary septotomy” 
or “transpancreatic sphincter precut” 
or “transpancreatic duct precut” 
or “pancreatic sphincter precutting” 
or “pancreatic precut sphincterotomy” 
or “transpancreatic precut septotomy” 
or “transpancreatic precut septostomy” 
or “pancreatic septotomy” 
or “pancreatic septostomy” 
or “pancreatic precut” 
or “transpancreatic precut” 
or “transpancreatic”
63 publications assessed for eligibility 
13 studies included for qualitative synthesis
286 articles excluded as title and/or abstract not 
relevant
50 publications excluded:
▪ Review or meta-analysis 14
▪ Other types of intervention 35
▪ Only available as abstract 1 
▶ Fig. 1 Flow diagram of the literature search.
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Six out of the thirteen studies reported that there was no dif-
ference in the sex and age distribution between the NKPP and
TPS groups [17, 19, 21, 24–26] (▶Table3). The other studies
reported the male/female ratio and the mean age only for all
of the involved patients together. The mean ages of the patient
groups varied between 49 and 79 years in the analyzed studies.
The number of women was more than double the number of
men in the study of Huang et al. [22]; one study did not report
these data [20]; while all the other studies reported nearly
equal sex distribution (▶Table 3).
Six of the analyzed studies [17, 19, 21, 24–26] also compar-
ed the indications for ERCP in the NKPP and TPS groups; only
one study [24] showed significant differences for some of the
indications. The indications were not separately analyzed in
the other studies, but in general there were no major differen-
ces between the studies (▶Table 3).
The experience of the endoscopist performing the different
advanced cannulation techniques was not reported in three
studies [20, 21, 25]; among these, only one study was carried
out in a center with lower case volume (approximately 200
ERCPs/year) [21]. Experienced endoscopists performed the
procedure in the other studies, although one study reported
trainee involvement at the initial cannulation attempt [19],
and another stated that approximately one-quarter of the in-
terventions were performed by endoscopists with lower case-
loads (≤3 ERCPs/week) [26] (▶Table 3).
NKPP was performed in those patients where the pancreatic
duct was not accessible in four studies [16, 18, 20, 26]. TPS or
NKPP was randomly selected in three studies [14, 17, 25], while
it was left to the preference of the endoscopist in the other
studies.
Cannulation success
Four studies found that TPS was significantly better for cannu-
lation success [15, 17, 20, 24]; one study showed just a tenden-
cy toward a better cannulation rate for TPS [14]; while no differ-
ences were found in the other studies.
Our data analysis allowed us to conclude that NKPP is signif-
icantly inferior to TPS with regard to cannulation success in
terms of both OR (OR 0.50, 95%CI 0.25–0.99; P=0.046; n =
812 vs. 972; Q=50.21, degrees of freedom [df(Q)] 12; P<
0.001; I2=76.10%; ▶Fig. 6) and RR (RR 0.92, 95%CI 0.85–
0.99; P=0.03; ▶Table 4). The difference was even more signifi-
cant when the meta-analysis was carried out using data from
the prospective studies only [14–18]. In this comparison, the
OR was 0.43 (95%CI 0.26–0.72; P=0.001; n =260 vs. 292; Q=
4.29, df(Q) 4; P=0.37; I2 =6.85%; ▶Fig. 7). The inferiority was
also seen with a similar level of significance when RR values
were calculated in the comparison of NKPP and TPS (RR 0.87,
95%CI 0.82–0.94; P<0.001; ▶Table 4).
A separate analysis was performed that excluded the studies
with sequential design. In this case, the difference between the
▶Table 2 Characteristics of studies comparing NKPP and TPS that were included in the meta-analysis.
Study Study design Quality of study Number of included patients in the
different treatment groups
Jadad scale1
(0–5)
MINORS2
(0–24)
NKPP TPS
Catalano MF, 2004 [14] Prospective, randomized 1 –  32  31
Espinel-Díez J, 2013 [15] Prospective, non-randomized – 16  74 125
Zang J, 2014 [17] Prospective, randomized 3 –  76  73
Kim CW, 2015 [16] Prospective, non-randomized,
sequential
– 16  58  38
Zou XP, 2015 [18] Prospective, non-randomized,
sequential
– 22  20  25
Horiuchi A, 2007 [21] Retrospective – 14  30  48
Kapetanos D, 2007 [23] Retrospective – 14  15  40
Halttunen J, 2009 [20] Retrospective – 10 157 262
Wang P, 2010 [26] Retrospective – 18  76 140
Chan CHY, 2012 [19] Retrospective – 16  66  53
Katsinelos P, 2012 [24] Retrospective – 14 129  67
Miao L, 2015 [25] Retrospective – 16  33  36
Huang C, 2016 [22] Retrospective – 14  46  34
MINORS, Methodological Index for Non-Randomized Studies.
1 Jadad scale: 0 = very poor, 5= rigorous. Jadad AR et al. [9].
2 MINORS: 12 items are scored (0 =not reported; 1= reported, but inadequate; 2= reported and adequate). The global ideal score is 16 for non-comparative studies
and 24 for comparative studies. Slim K et al. [10].
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▶Table 4 Relative risk (RR) calculations for success rates in the needle-knife precut papillotomy (NKPP) and transpancreatic biliary sphincterotomy
(TPS) groups.
Comparison Included studies RR1 95%CI P value
Success rate All 0.92 0.85–0.99 0.032
Prospective 0.87 0.82–0.94 <0.001
Non-sequential 0.92 0.85–1.00 0.047
PEP rate All 0.80 0.58–1.11 0.19
Prospective 0.51 0.27–0.97 0.04
Non-sequential 0.93 0.63–1.37 0.72
Bleeding rate All 2.18 1.15–4.13 0.02
Prospective 1.01 0.32–3.16 0.98
Non-sequential 2.40 1.25–4.60 0.008
Total complication rate All 1.17 0.72–1.78 0.47
Prospective 0.61 0.36–1.02 0.06
Non-sequential 1.33 0.96–1.83 0.08
CI, confidence interval; PEP, post-endoscopic retrograde cholangiopancreatography pancreatitis.
1 RR<1 indicates a lower rate in the NKPP group.
2 Numbers in bold represent statistically significant differences.
Study name Study type Statistics for each study Events/Total Odds ratio and 95 % Cl
 Odds Lower Upper
 ratio limit limit P value NKPP TPS
Catalano MF, 2004* prospective 0.21 0.04 1.07 0.060 24/32 29/31
Espinel-Díez J, 2013 prospective 0.32 0.13 0.82 0.017 61/74 117/125
Zang J, 2014* prosepctive 0.23 0.06 0.85 0.027 64/76 70/73
Kim CW, 2015 prospective 0.68 0.28 1.67 0.400 38/58 28/38
Zou XP, 2015 prospective 0.91 0.25 3.31 0.883 14/20 18/25
Horiuchi A, 2007 retrospective 0.39 0.06 2.49 0.321 27/30 46/48
Kapetanos D, 2007 retrospective 0.92 0.24 3.54 0.899 11/15 30/40
Halttunen J, 2009 retrospective 0.07 0.03 0.16 0.000 112/157 255/262
Chan CHY, 2012 retrospective 1.48 0.66 3.30 0.344 50/66 36/53
Katsinelos P, 2012 retrospective 0.04 0.00 0.63 0.022 108/129 67/67
Wang P, 2010 retrospective 2.04 0.83 4.98 0.118 69/76 116/140
Miao L, 2015 retrospective 0.91 0.05 15.23 0.950 32/33 35/36
Huang C, 2016 retrospective 1.26 0.43 3.71 0.669 37/46 26/34
  0.50 0.25 0.99 0.046 647/812 873/972
0.01
Favours NKPPFavours TPS
0.1 1 10 100
▶ Fig. 6 Forest plot of studies that evaluated success rate in needle-knife precut papillotomy (NKPP) and transpancreatic biliary
sphincterotomy (TPS) groups (data pooled from all of the studies). CI, confidence interval.
* Prospective randomized trial.
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two methods did not reach the level of statistical significance,
but a tendency toward inferiority of the NKPP technique could
be seen (OR 0.45, 95%CI 0.20–1.02; P=0.06; n =734 vs. 909; Q
=49.18, df(Q) 10; P<0.001; I2 =79.67%). The RR calculation
from these studies revealed a significantly lower success rate
in the NKPP group compared with the TPS group (RR 0.92, 95
%CI 0.85–1.00; P=0.047) (▶Table 4).
PEP rates
Only one study found NKPP significantly superior to TPS in
terms of PEP rates [16], while the remaining articles found no
difference between the two cannulation methods. An analysis
of the pooled data did not reveal a statistical difference in PEP
rates (OR 0.79, 95%CI 0.53–1.17; P=0.24; n=794 vs. 939; Q=
12.07, df(Q) 11; P=0.36; I2 =8.85%) (▶Fig. 8). The difference in
PEP rates was close to the level of significance when only the
prospective studies [14–17] were analyzed. There was a tend-
ency toward lower PEP rates in the NKPP group (OR 0.49, 95%CI
0.23–1.01; P=0.052; n=242 vs. 265; Q= 6.947, df(Q) 3; P=
0.07; I2 =56.82%), while the RR calculation showed a signifi-
cantly lower rate of PEP in this analysis (RR 0.51, 95%CI 0.27–
0.97; P=0.04) (▶Table 4).
No significant difference was found between the two tech-
niques when the studies with non-sequential design were sep-
arately analyzed (OR 0.93, 95%CI 0.63–1.37; P=0.72; n =736
vs. 901; Q=4.96, df(Q) 10; P=0.89; I2 =0%).
Bleeding rates
The bleeding rates after TPS or NKPP did not differ significantly
in any of the analyzed studies. Our meta-analysis showed that
there is significantly more bleeding after NKPP compared with
TPS (OR 2.24, 95%CI 1.17–4.31; P=0.02, n =745 vs. 908; Q=
5.21, df(Q) 9; P =0.82; I2=0%) (▶Fig. 9). An analysis of the
non-sequential studies showed the same results: NKPP was
found to cause significantly more bleeding than TPS (OR 2.48,
95%CI 1.27–4.84; P=0.008; n =687 vs. 870; Q=5.21, df(Q) 9;
P =0.82; I2 =0%).
An analysis of the data extracted from the prospective stud-
ies [14–17] revealed no difference in bleeding rates: OR 1.013,
95%CI 0.32–3.16; P=0.98, n =239 vs. 268; Q=3.324, df(Q) 3; P
=0.34; I2 =9.75%.
The RR values for bleeding rate from all the studies, from
prospective studies only, and from non-sequential studies
showed the same differences (▶Table4).
Perforation rates
The perforation rates did not differ significantly in any of the
analyzed studies. Altogether, seven perforations were reported
after NKPP, while only one occurred after TPS. This difference
was not statistically significant in our analysis (RD 0.01, 95%CI
0.00–0.02; P=0.23; n=812 vs. 942; Q=2.06, df(Q) 12; P >0.99;
I2=0%). The RD similarly did not show any differences between
the groups in the separate analyses of prospective and non-se-
quential studies.
Total complication rates
Only one study [16] found that NKPP had significantly fewer to-
tal adverse events than TPS; the other studies did not find any
differences. Our analysis found no difference between the two
methods with regard to the total complication rates (OR 1.22,
95%CI 0.74–2.00; P=0.44; n=794 vs. 939; Q=23.48, df(Q)
11; P =0.02; I2=53.15%).
Excluding the studies with sequential design revealed a
tendency for NKPP to cause more total complications than TPS
(OR 1.33, 95%CI 0.96–1.83; P=0.08; n =736 vs. 901; Q=7.88,
df(Q) 10; P =0.64; I2=0%) (▶Fig. 10). Calculations of RR, simi-
larly to the OR values, did not show significant differences in
the NKPP and TPS groups (▶Table 4).
Study name Study type Statistics for each study Events/Total Odds ratio and 95 % Cl
 Odds Lower Upper
 ratio limit limit P value NKPP TPS
Catalano MF, 2004* prospective 0.21 0.04 1.07 0.060 24/32 29/31
Espinel-Díez J, 2013 prospective 0.32 0.13 0.82 0.017 61/74 117/125
Zang J, 2014* prosepctive 0.23 0.06 0.85 0.027 64/76 70/73
Kim CW, 2015 prospective 0.68 0.28 1.67 0.400 38/58 28/38
Zou XP, 2015 prospective 0.91 0.25 3.31 0.883 14/20 18/25
  0.43 0.26 0.72 0.001 201/260 262/292
0.01
Favours NKPPFavours TPS
0.1 1 10 100
▶ Fig. 7 Forest plot of studies that evaluated success rate in needle-knife precut papillotomy (NKPP) and transpancreatic biliary sphincterotomy
(TPS) groups (data pooled from the prospective studies). CI, confidence interval.
* Prospective randomized trial.
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Study name Study type Statistics for each study Events/Total Odds ratio and 95 % Cl
 Odds Lower Upper
 ratio limit limit P value NKPP TPS
Catalano MF, 2004* prospective 3.37 0.39 35.46 0.251 4/34 1/29
Espinel-Díez J, 2013 prospective 0.41 0.05 3.78 0.435 1/74 4/125
Zang J, 2014* prosepctive 0.96 0.27 3.46 0.947 5/76 5/73
Kim CW, 2015 prospective 0.20 0.07 0.58 0.003 6/58 14/38
Horiuchi A, 2007 retrospective 1.62 0.10 26.92 0.736 1/30 1/48
Kapetanos D, 2007 retrospective 0.72 0.03 18.71 0.844 0/15 1/34
Halttunen J, 2009 retrospective 0.56 0.24 1.28 0.168 8/157 23/262
Wang P, 2010 retrospective 1.04 0.44 2.48 0.928 9/76 16/140
Chan CHY, 2012 retrospective 1.21 0.20 7.55 0.835 3/66 2/53
Katsinelos P, 2012 retrospective 0.92 0.45 1.87 0.814 27/129 15/67
Miao L, 2015 retrospective 2.34 0.40 13.74 0.345 4/33 2/36
Huang C, 2016 retrospective 1.50 0.13 17.25 0.745 2/46 1/34
  0.79 0.53 1.17 0.235 70/794 85/939
0.01
Favours TPSFavours NKPP
0.1 1 10 100
▶ Fig. 8 Forest plot of studies that evaluated post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) rate in needle-knife
precut papillotomy (NKPP) and transpancreatic biliary sphincterotomy (TPS) groups (data pooled from all of the studies). CI, confidence interval.
* Prospective randomized trial.
Study name Study type Statistics for each study Events/Total Odds ratio and 95 % Cl
 Odds Lower Upper
 ratio limit limit P value NKPP TPS
Catalano MF, 2004* prospective 4.54 0.21 98.45 0.335 2/34 0/29
Espinel-Díez J, 2013 prospective 0.55 0.11 2.80 0.473 2/74 6/125
Zang J, 2014* prosepctive 3.21 0.33 31.63 0.317 3/73 1/76
Kim CW, 2015 prospective 0.21 0.01 5.38 0.349 0/58 1/38
Horiuchi A, 2007 retrospective 8.51 0.39 183.55 0.172 2/30 0/48
Kapetanos D, 2007 retrospective 5.08 0.42 60.91 0.200 2/15 1/34
Halttunen J, 2009 retrospective 2.12 0.56 8.02 0.268 5/157 4/262
Wang P, 2010 retrospective 2.84 0.46 17.35 0.259 3/76 2/140
Chan CHY, 2012 retrospective 3.35 0.36 30.95 0.286 4/66 1/53
Katsinelos P, 2012 retrospective 5.96 0.32 109.50 0.229 5/129 0/67
Miao L, 2015 retrospective 5.79 0.27 125.25 0.263 2/33 0/36
  2.24 1.16 4.31 0.016 30/745 16/908
0.01
Favours TPSFavours NKPP
0.1 1 10 100
▶ Fig. 9 Forest plot of studies that evaluated the post-papillotomy bleeding rate in needle-knife precut papillotomy (NKPP) and transpancreatic
biliary sphincterotomy (TPS) groups (data pooled from all of the studies). CI, confidence interval.
* Prospective randomized trial.
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Discussion
Our meta-analysis indicates that TPS is more effective than
NKPP with regard to the success of biliary tract cannulation.
On the other hand, the PEP rate, the most frequent adverse
event after ERCP, did not differ between the TPS and the NKPP
groups when all the studies were analyzed together. The PEP
rate was lower in the NKPP group in the separate analysis of
prospective studies. The bleeding rate was lower after perform-
ing TPS in the analysis of all studies, while there was no differ-
ence between the bleeding rates of the two techniques if the
prospective studies only were analyzed separately. Perforation
rates did not differ statistically in the analysis of the two tech-
niques, although only one perforation was observed after TPS in
the analyzed studies, while seven perforations occurred after
the NKPP technique.
It should be pointed out that TPS is not for novice endos-
copists because multiple guidewire insertions or contrast injec-
tion into the pancreatic duct, thermal injury during papillot-
omy, and many other factors can cause PEP. Experienced
endoscopists performed the procedures in almost all analyzed
studies, which was an important factor in the high rate of can-
nulation success and low rate of complications. Adherence to
the current guidelines regarding the prevention of PEP is also
very important after TPS; therefore, insertion of a short 5-Fr
pancreatic stent and administration of a non-steroidal supposi-
tory are strongly advised in this situation.
No difference in the total complication rates for the two
groups was found; however, a significant asymmetry of the fun-
nel plot analysis was detected in this case, which indicates pub-
lication bias that could have altered the results. Unfortunately,
the less frequent adverse events, like cholangitis, sepsis, and
procedure-related death, among others, were not analyzable
because most of the studies did not report them. Mean cannu-
lation times, procedure times, and radiation doses during the
different cannulation techniques would also be interesting to
compare, but these important data were only included in a
minority of the studies. An analysis of these parameters, there-
fore, could not be performed.
We excluded one study that was published only in abstract
form from the analysis. The study of Kawaguchi et al. is a retro-
spective data analysis with small sample size (22 patients with
TPS vs. 10 patients with NKPP) [28]. They found no difference
between the two techniques regarding cannulation success
rate (P =0.73), but NKPP had a significantly higher PEP rate (P =
0.02), while the bleeding and total complication rates were not
reported.
There are several limitations to this meta-analysis. Firstly,
there was significant heterogeneity among the studies with re-
gard to cannulation success and total complication rate. The
heterogeneity disappeared when the prospective studies were
analyzed separately for cannulation success and when the two
studies with sequential design were excluded in the analysis of
total complication rate.
Several factors could have caused the heterogeneity among
these studies. Difficult biliary access was defined with great
variability in the analyzed studies, while other outcome meas-
ures were much more uniform. Although the definition of diffi-
cult cannulation has not yet been standardized, only the study
of Huang et al. [22] fulfilled the criteria that were suggested in
Study name Study type Statistics for each study Events/Total Odds ratio and 95 % Cl
 Odds Lower Upper
 ratio limit limit P value NKPP TPS
Catalano MF, 2004* prospective 6.00 0.68 53.12 0.107 6/34 1/29
Espinel-Díez J, 2013 prospective 0.75 0.25 2.25 0.609 5/74 11/125
Zang J, 2014* prosepctive 1.11 0.38 3.23 0.849 8/76 7/73
Horiuchi A, 2007 retrospective 5.22 0.52 52.72 0.161 3/30 1/48
Kapetanos D, 2007 retrospective 2.46 0.31 19.38 0.392 2/15 2/34
Halttunen J, 2009 retrospective 0.99 0.51 1.90 0.970 16/157 27/262
Wang P, 2010 retrospective 1.35 0.64 2.86 0.427 14/76 20/140
Chan CHY, 2012 retrospective 1.98 0.49 8.05 0.341 7/66 3/53
Katsinelos P, 2012 retrospective 1.19 0.59 2.39 0.622 33/129 15/67
Miao L, 2015 retrospective 3.52 0.85 14.64 0.083 8/33 3/36
Huang C, 2016 retrospective 2.30 0.23 23.15 0.479 3/46 1/34
  1.33 0.96 1.83 0.084 105/736 91/901
0.01
Favours TPSFavours NKPP
0.1 1 10 100
▶ Fig. 10 Forest plot of studies evaluating total complication rate in needle-knife precut papillotomy (NKPP) and transpancreatic biliary
sphincterotomy (TPS) groups (data pooled from prospective and retrospective studies, excluding ones with sequential design). CI, confidence
interval.
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the recent ESGE guideline [1]. The majority of the studies used
a more permissive definition, while two studies [20, 24] did not
define it (▶Table 5). This theoretically might increase the rate
of complications without influencing the success rate. Less het-
erogeneity was observed in the adverse events. Only the oldest
study [14] did not specify how PEP was diagnosed, with all the
other studies using the consensus criteria. Bleeding definition
was in accordance with the consensus criteria in 10 out of 13
studies; two studies did not specify the definition [20, 22]; and
another used different criteria [25] (▶Table5).
Unfortunately, very few randomized studies that analyze the
efficacy and adverse event rates of advanced biliary cannula-
tion methods are available in the literature. Differences in the
study design might also have caused heterogeneity. We identi-
fied two studies, where TPS was only performed after DGW-as-
sisted biliary access failed [16, 18]. These sequential attempts
at biliary access might increase the rate of successful cannula-
tion, but might also cause more adverse events as more papil-
lary injury is induced this way.
In our analysis, the success rate was not influenced by the in-
clusion of these sequential studies, because only data from
those patients who underwent a TPS attempt were included,
while patients in the sequential DGW–TPS group with success-
ful DGW-assisted cannulation were left out. The inclusion or ex-
clusion of sequential studies from the meta-analysis did not in-
fluence the two most frequent adverse events: PEP rates were
the same, while the bleeding rate was less in the TPS group
than in the NKPP group, irrespective of the study design.
Secondly, the majority of the included studies contained ret-
rospective outcome data. We also investigated the prospective
studies separately, but the small number of prospective studies
may limit the value of this separate analysis. The advantage of
TPS in terms of successful cannulation was stronger when the
prospective data were analyzed separately and the degree of
heterogeneity was much lower. However, with regard to PEP
rates, the degree of heterogeneity was higher when the pro-
spective studies were analyzed separately and the RR of PEP fa-
vored the NKPP group, while the OR calculation did not show a
statistical difference. The bleeding rate was lower in the TPS
group than in the NKPP group in the analysis of all studies, but
there was no difference in the analysis of the prospective stud-
ies, while a low degree of heterogeneity was observed in both
analyses. Publication bias may have influenced this outcome
because, in the analysis of all studies, a significant asymmetry
was detected. However, funnel plot asymmetry and publication
bias could not be assessed in the analysis of the prospective
studies because of the low number of studies.
Thirdly, some of the analyzed studies did not specify the de-
finition of bleeding after the intervention [20, 22] or used a dif-
ferent definition [25] compared with the consensus criteria
(▶Table5) [29]. Furthermore, one of the selected studies [14]
did not specify whether the consensus criteria were used to de-
fine PEP (▶Table5) [29]. Despite this heterogeneity, it is not
likely that omitting this small number of studies from the final
analysis would have altered our results.
The studies in our analysis were also heterogeneous with re-
gard to the prophylaxis of PEP (▶Table 5). It would also have
been worth comparing PEP rates between subgroups where
prophylactic measures were applied and those subgroups
where no prophylaxis was given but, unfortunately, we could
not extract sufficient data for such an analysis. Recent guide-
lines strongly recommend attempting prophylactic pancreatic
stent (PPS) insertion in all patients who have had PGW-assisted
methods used for biliary cannulation, along with routine rectal
administration of diclofenac or indomethacin in all patients
without a contraindication [1, 30]. Some of the studies were
conducted before these guidelines were published, and PPS
was not used uniformly in cases when the pancreatic duct was
manipulated. Furthermore, no information was found on the
administration of non-steroidal anti-inflammatory medication
in these studies, which can also influence the rate of PEP. The
outcome of the studies regarding this adverse event might
have been different if these preventive measures had been uni-
formly applied (▶Table5).
If there is unintended PGW insertion or pancreas cannula-
tion, the endoscopist can choose to continue directly with TPS
or any of the precut techniques (NKPP or NKF), or to continue
guidewire-assisted cannulation with a second guidewire
(DGW). The latter possibility is seemingly less invasive than
TPS or the precut techniques. Only two studies [16, 18] in this
meta-analysis used DGW before TPS was attempted, and the
rate of successful biliary access was similar to the NKPP group
where the pancreatic duct was not accessed. A recent meta-a-
nalysis also showed that DGW does not improve biliary access
but, on the other hand, almost doubles the risk of PEP where
cannulation is difficult (RR 1.98, 95%CI 1.14–3.42) [31].
According to our best knowledge, the three remaining op-
tions in this situation (TPS, NKPP, and NKF) have not yet been
compared in any prospective studies. Based on this meta-anal-
ysis, TPS may be better than NKPP, but it is hard to tell whether
NKF is superior or not. The cutting can be controlled more easi-
ly during TPS than in the freehand technique of NKF (or NKPP),
because the position of the papillotome is stabilized by the
PGW. This might prevent bleeding and perforation, while the
risk of PEP can be reduced by PPS insertion.
It would be interesting to compare TPS and NKF as these two
methods are recommended after failed PGW-assisted biliary
cannulation in the ESGE guideline [1], but only a few articles
that studied these two techniques alongside each other were
identified during our search. Lee et al. [32] did not show any dif-
ference in success or adverse event rates between the two
techniques in their study. The patients were not randomized
and fistulotomy was attempted only in a small proportion of
patients (n =19) when the pancreatic duct was not accessible.
Horiuchi et al. [21] selected the different cannulation methods
based on the morphology of the major papilla. They applied the
NKPP technique in patients with a large papillary tract with a
90% success rate. The NKF technique was carried out when a
swollen papilla was identified (only in eight patients); the bili-
ary cannulation success rate was 100%, without any complica-
tions. TPS, on the other hand, was used in patients with a small
papillary tract and was successful in 48 patients (96%), with
one case of pancreatitis. In the study by Katsinelos et al. [24],
NKPP, TPS, and NKF were all compared. NKF had a 92% initial
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cannulation success rate (in 78 patients), while TPS was suc-
cessful in all cases (67 patients). In this study, the overall com-
plication rate and the PEP rate were significantly lower in the
NKF group than in the groups managed with the other tech-
niques.
Differences in the timing of TPS or NKPP after failed biliary
access can also cause considerable differences in the outcome.
A recent meta-analysis showed that early precut can signifi-
cantly decrease the PEP rate compared with persistent at-
tempts, while not influencing the cannulation rate and overall
complication rate [33]. Our meta-analysis showed that, despite
▶Table 5 Definitions of difficult biliary access and of the possible complications that were used in the included studies.
Study Difficult biliary access PEP Bleeding PEP prophylaxis
Catalano MF, 2004
[14]
Cannulation was unsuccessful after
more than 30 minutes
and/or the pancreatic duct had been
injected multiple times
Not defined Consensus
criteria
PPS in some of the patients,
drugs were not used
Espinel-Díez J, 2013
[15]
More than five failed attempts to
selectively cannulate the bile duct
Consensus
criteria
Consensus
criteria
Neither PPS nor drugs were used
Zang J, 2014 [17] Standard cannulation was unsuccessful
within 10 minutes
and/or pancreatic duct insertion was
attempted five times
Consensus
criteria
Consensus
criteria
Neither PPS nor drugs were used
Kim CW, 2015 [16] 10 unsuccessful attempts to selectively
cannulate the bile duct
Consensus
criteria
Consensus
criteria
PPS after TPS in the latter half of
the study, drugs were not used
Zou XP, 2015 [18] Cannulation could not be accomplished
by more than two experts
cannulation time >30 minutes
and more than five accidental pancreatic
duct passages
Consensus
criteria
Consensus
criteria
PPS in some of the patients
(suspected SOD, multiple
contrast injection), drugs were
not used
Horiuchi A, 2007
[21]
> 15 minutes
and/or the pancreatic duct had been
injected/opacified multiple times
Consensus
criteria
Consensus
criteria
Neither PPS nor drugs were used
Kapetanos D, 2007
[23]
> 10 attempts to selectively cannulate the
bile duct
Consensus
criteria
Consensus
criteria
No PPS, pentoxifylline in some
patients (no effect of pentoxi-
fylline on pancreatitis rates was
shown in the original study [27])
Halttunen J, 2009
[20]
Not defined Consensus
criteria
Not defined PPS in a small number of
patients, drugs were not used
Wang P, 2010 [26] Multiple unsuccessful attempts to selectively
cannulate the bile duct
Consensus
criteria
Consensus
criteria
PPS in a small number of
patients, drugs were not used
Chan CHY, 2012
[19]
At the discretion of the endoscopist Consensus
criteria
Consensus
criteria
PPS in some of the patients,
drugs were not used
Katsinelos P, 2012
[24]
Not defined Consensus
criteria
Consensus
criteria
PPS and drugs in a small number
of patients
Miao L, 2015 [25] Failing to enter the bile duct but repeated
(more than three times) insertion of the
catheter into the pancreatic duct, a
pancreatic guidewire or plastic stent was
placed, and bile duct cannulation was
attempted again
Consensus
criteria
Vomiting or
black stools
after ERCP
or hemoglobin
< 95% of normal
level within 24
hours
All patients had PPS, drugs were
not used
Huang C, 2016 [22] More than five contacts with the papilla
during the attempt to cannulate
> 5 minutes attempting to cannulate
or more than one unintentional pancreatic
duct cannulation
Consensus
criteria
Not defined PPS after repeated cannulation
or injection, indomethacin
suppository in the later phase
of the study
PEP, post-endoscopic retrograde cholangiopancreatography pancreatitis; PPS, prophylactic pancreatic stent; ERCP, endoscopic retrograde cholangiopancreatogra-
phy; SOD, sphincter of Oddi dysfunction; TPS, transpancreatic sphincterotomy; CBD, common bile duct.
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the time before the precut being variable in the included stud-
ies, the biliary cannulation rate with TPS was better and the PEP
risk was similar.
Data about the long-term consequences of pancreatic
sphincterotomy are scarce. As with biliary sphincterotomy,
papillary stenosis can develop following a small incision, and
proximal pancreatic duct stricture can also occur [34]. PPS is
an important tool to prevent PEP, which is probably the most
significant early complication of pancreatic sphincterotomy.
Sometimes PPS itself can cause pancreatic duct and parenchy-
mal injury, especially in patients with a normal caliber pancreat-
ic duct [35]. However, the true prevalence of these changes,
and therefore the long term clinical significance, is not yet
known.
In summary, the present meta-analysis indicates that TPS in-
creases the rate of biliary access compared with NKPP in pa-
tients with difficult CBD cannulation. This comes with a de-
creased frequency of bleeding, but the risk of total adverse
events does not differ. These findings might reduce the prejudi-
ces against TPS and promote its more frequent application in
patients with difficult biliary access, but low volume centers
with less expertise in ERCP are not advised to use this tech-
nique.
Our suggested algorithm for patients with difficult biliary
access would be precut papillotomy (preferably NKF) if a PGW
cannot be inserted, or TPS after insertion of a PGW, followed
by appropriate PEP prophylaxis. Further prospective multicen-
ter studies are needed to compare the effectiveness and true
adverse event rates for TPS and other advanced cannulation
techniques when the current recommendations of early precut
and prophylactic measures to prevent PEP are uniformly fol-
lowed.
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